Denver lab developing first-of-its-kind tool for early ovarian cancer detection - CBS Colorado
Early detection of ovarian cancer is challenging, with 80% diagnosed at late stages. AOA Diagnostics, a Denver-based startup, is developing a blood test for early detection, aiming to transform women's healthcare. The company, founded during the COVID-19 pandemic, is at the forefront of innovation in Colorado, conducting a clinical study for their groundbreaking technology.
Reference News
Early detection of ovarian cancer is challenging, with 80% diagnosed at late stages. AOA Diagnostics, a Denver-based startup, is developing a blood test for early detection, aiming to transform women's healthcare. The company, founded during the COVID-19 pandemic, is at the forefront of innovation in Colorado, conducting a clinical study for their groundbreaking technology.